DRTS ▲ +7.8% - Alpha Tau Medical Ltd.
$DRTS DRTSW - Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
19-OCT-2026 08:30 AM ET
Share this post
More filings for $DRTS
DRTS ▲ +0.7% - Alpha Tau Medical Ltd.Oct 5, 2026DRTS ▲ +0.3% - Alpha Tau Medical Ltd.Sep 2, 2026DRTS ▲ +0.8% - Alpha Tau Medical Ltd.Aug 31, 2026
View full $DRTS filing history →💬 Comments
Loading comments…
Leave a comment
